Work

Phase 1 study of BPM 31510 (Ubidecarenone) in patients with advanced solid tumors (ST): Use of multiomics platform to evaluate reversal of Warburg effect.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.2539

Authors: Ralph Zinner, Peter Paul Yu, Niven R. Narain, Rangaprasad Sarangarajan, Michael Kiebish, Vivek Vishnudas, Yezhou Sun, Leonardo Rodrigues, Viacheslav R Akmaev, Susan Brouwer, Janice Stevens, Ely Benaim, Manish A. Shah

Institutions: The University of Texas MD Anderson Cancer Center, Palo Alto Medical Foundation, Berg (United States), Weill Cornell Medicine

Language: English

Topic: Cancer, Hypoxia, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2598285126

Cites:

Cited by:

Related to: 10